Live Breaking News & Updates on ஈவா மார்சேஸ்

Stay updated with breaking news from ஈவா மார்சேஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Overcoming Funding Challenges For Innovative Medtech In Germany Learnings From The NUB Process


Overcoming Funding Challenges For Innovative Medtech In Germany: Learnings From The NUB Process
By Eva Marchese, Lorenzo D’Angelo, Anthony Barron, and Oriol Viader-Llargués, CRA
Germany is the leading medtech market in Europe, with a 22% market share. While funding for high-cost innovative medtech in Germany has evolved in recent years, there are still many challenges in securing reimbursement even as demand for these technologies surges. In a new analysis conducted by our Life Sciences Practice team at CRA, we explored how medtech companies should approach the reimbursement pathway for these devices when seeking to enter the German market.
In Germany, there are multiple pathways for medtech reimbursement depending on whether it is for capital equipment, for general reimbursement of outpatient services, for home use, or for use in the inpatient setting. In the inpatient setting, reimbursement for a treatment or procedure is determined via the German Diagnosis Relate ....

Bruxelles Capitale , City Of , United Kingdom , Anthony Barron , Eva Marchese , Neue Untersuchungs , Lorenzo Dangelo , Oriol Viader Llargu , Research Group , Life Sciences Practice , Piggy Bank , Life Sciences , Committee Gemeinsamer Bundesausschuss , Lorenzod Angelo , German Diagnosis Related Groups , Hospital Remuneration System , Devices Directive , Federal Joint Committee , Gemeinsamer Bundesausschuss , ப்ரூக்ஸெல்ஸ் தலைநகரம் , நகரம் ஆஃப் , ஒன்றுபட்டது கிஂக்டம் , அந்தோணி பரோன் , ஈவா மார்சேஸ் , லோரென்சோ டாங்கெலோ , ஆராய்ச்சி குழு ,

The market access challenge


The market access challenge
Digital health technologies are failing to reach their potential to boost the quality and efficiency of healthcare systems, largely because of a lack of dedicated access pathways or value assessment processes
Digital health is an emerging and rapidly developing field with the potential to increase the quality and efficiency of healthcare systems. The rise of digital health technologies (DHTs) has been driven by an increase in non-communicable diseases and a desire by patients to take a more active role in the management of their condition and is now being accelerated by the COVID-19 pandemic. DHTs have the potential to allow payers and manufacturers to track patient outcomes and adherence better, faster and more accurately, and hence support wider adoption of value-based healthcare models. ....

United States , United Kingdom , Bruxelles Capitale , City Of , Anthony Barron , Eva Marchese , Lorenzo Dangelo , Digital Health Center , National Institute For Health , Life Sciences Practice , Charles River Associates , Technology Payment , Technology Tariff , Healthcare Innovation Hub , Digital Healthcare , National Institute , Care Excellence , Medtech Innovation , Prescription Digital Therapeutics , Support Recovery Act , Social Security , Latin America , Digital Healthcare Act , Lorenzod Angelo , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் ,